Northwestern Mutual Foundation

The mission of the Northwestern Mutual Foundation is to improve the lives of children and families in need. The Foundation has given more than $35 million since its inception in 1992 and is designed to create lasting impact in the communities where the company's employees and financial representatives live and work. We accomplish this by combining financial support, volunteerism, thought leadership and convening community partners to deliver the best outcomes. Our efforts are focused nationally on curing childhood cancer, and locally on education, neighborhoods and making our hometown of Milwaukee a great destination.

Visit Northwestern Mutual Foundation for more information

Co-Funded Projects

Project Title	Institutions	Co-Funder(s)
Novel Role of Hematopoietic Stem Cells in Immunologic Rejection of Malignant Pediatric Brain Tumors	University of Florida	Northwestern Mutual Foundation
Targeting Secondary Mutations in Juvenile Myelomonocytic Leukemia	University of California San Francisco	Northwestern Mutual Foundation
CAMKV as a Target for Immunotherapy in MYCN-Amplified Neuroblastoma	Children’s Hospital of Philadelphia	Northwestern Mutual Foundation
Enhancing Effectiveness of Immune Checkpoint Therapy in Neuroblastoma	Children’s Hospital Los Angeles	Northwestern Mutual Foundation
Identifying how Pre-existing Anti-Therapeutic Antibodies (PATA) are Associated with Better Outcome in a Clinical Trial of ADCC-inducing Anti-GD2 mAb	University of Wisconsin - Madison	Northwestern Mutual Foundation
Building Capacity for the Clinical Trials Office at Children's Hospital of Wisconsin - Strengthening Phase I & II Trials Infrastructure	Children’s Hospital of Wisconsin - Milwaukee	Northwestern Mutual Foundation
DNA Sequencing Using Malaria Slides	Indiana University	Northwestern Mutual Foundation
A Developmental Model to Characterize the Epigenetic Origins of the Retinoblastoma Tumor Initiating Cell	The Johns Hopkins University School of Medicine	Northwestern Mutual Foundation
Development of Targeted DNA-damaging Therapy for ATRX-deficient Pediatric Glioblastoma	University of Michigan	Northwestern Mutual Foundation
Identification of Resistance Mechanisms and Novel Therapeutic Strategies in Tyrosine Kinase Inhibitor Resistant FLT3/ITD Acute Myeloid Leukemia	Fred Hutchinson Cancer Research Center	Northwestern Mutual Foundation

Project Title

Institutions

Co-Funder(s)

Novel Role of Hematopoietic Stem Cells in Immunologic Rejection of Malignant Pediatric Brain Tumors

University of Florida

Northwestern Mutual Foundation

Targeting Secondary Mutations in Juvenile Myelomonocytic Leukemia

University of California San Francisco

Northwestern Mutual Foundation

CAMKV as a Target for Immunotherapy in MYCN-Amplified Neuroblastoma

Children’s Hospital of Philadelphia

Northwestern Mutual Foundation